MX Bio Co., Ltd. is a bio company that develops specialized pharmaceuticals for the treatment of periodontal disease and peri-implantitis.

Its flagship product, ‘PERIMEDI,’ is a combination antibiotic ointment that simultaneously controls aerobic and anaerobic bacteria; it is an innovative treatment that has proven its efficacy and safety through Phase 3 clinical trials.

MX Bio is rapidly entering the market, focusing on hospitals and dental clinics, and is pursuing continuous growth through global partnerships and the expansion of indications.